|Bid||465.00 x 800|
|Ask||482.00 x 800|
|Day's range||467.32 - 478.30|
|52-week range||317.06 - 515.79|
|Beta (5Y monthly)||1.19|
|PE ratio (TTM)||55.85|
|Earnings date||31 Jul 2023 - 04 Aug 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||559.67|
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
WESTBROOK, Maine, May 10, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:15 pm (EDT).
In need of healthcare exposure in your portfolio? Consider holding these three promising companies forever.
Let's talk about the popular IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's shares received a lot of attention...
Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.
The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Idexx (IDXX) delivered earnings and revenue surprises of 7.14% and 1.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
WESTBROOK, Maine, May 02, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.
Over the past decade, spending on veterinary care has tripled in the United States. The growth in that spending makes veterinary care stocks somewhat recession proof. More and more, spending on pet healthcare is seen as something people need rather than want.
Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes.
IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.
Investors are optimistic about Zimmer Biomet's (ZBH) continued business recovery.
Masimo's (MASI) receipt of the FDA's clearance for the Rad-G with Temperature is expected to support clinicians in almost any care scenario.
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
WESTBROOK, Maine, April 13, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 first quarter results for Tuesday, May 2, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
ALC vs. IDXX: Which Stock Is the Better Value Option?
Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business.
IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) saw a double-digit share price rise of over 10% in the past couple of months...
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...